4 Comments

I have always felt that free cash flow based valuation multiples are faulty and undependable for deciding whether to buy or trim a stock. In 2023 many growth companies have been playing the FCF shell game trying to make their stock look more attractive while shareholder dilution and anemic growth continues behind the curtain. Revenue multiples are better suited for mature growth companies, not for hyper growth businesses. So that leaves us with forward growth based multiples being the better barometer showing that most of this universe is overvalued today.

Expand full comment

Why is "shareholder dilution" a bad sympton? Fast growing companies raising capital in the public markets is precisely a sign of growth and trust from the market, even though some shareholders dont keep up the pace and suffer dilution.

Expand full comment

When do you update the SaaS companies chosen in your charts? I'd like to see a few that are FCF positive now be included.

Expand full comment

Great point on growth adjusted valuation. It will be curious to see how the top quartile of growth companies valuation compare to past decade when rates were lower

Expand full comment